Ryan’s practice focuses on representing companies in the life science and information technology industries. These range from Fortune 500 enterprises to start-ups, and include medical device, software, pharmaceutical, and biotechnology companies. Ryan assists with disputes, strategy, corporate and transactional matters, as well as with obtaining intellectual property rights including patent, trademark, copyright and trade secret protections. His diverse educational and practice background allows him to contribute new perspectives and a business-oriented mindset to both conflicts and transactions. Managing Intellectual Property magazine named him as one of the fifty most influential people in intellectual property in 2019.
Outside of the firm, Ryan is a mediator and arbitrator with JAMS, Professor of Law and Health Sciences at the University of Surrey School of Law, and Adjunct Assistant Professor of Medicine at the David Geffen School of Medicine at UCLA. He is the author of The Reasonable Robot: Artificial Intelligence and the Law published by Cambridge University Press in 2020, and his legal research has also been published in a variety of leading journals and books. He is regularly featured in media outlets such as the New York Times, Wall Street Journal, and Financial Times. Ryan also works as an expert witness which has included testifying in federal court.
Ryan is a physician, attorney (licensed in California and New York), and patent attorney in the United States, as well as a solicitor advocate in England and Wales. He is board-certified by the American Board of Legal Medicine (ABLM). Ryan is a graduate of the University of Surrey School of Law (PhD), Yale Law School (JD), University of California, San Diego School of Medicine (MD), Emperor’s College (MTOM), and University of California, Los Angeles (BS).
University of Surrey School of Law
Yale Law School
University of California San Diego
School of Medicine M.D., 2011
summa cum laude
University of California Los Angeles
summa cum laude
California, New York, U.S.D.C.
Central District of California
Eastern District of New York
Southern District of New York
U.S.C.A., Federal Circuit
Registered Patent Attorney with the U.S. Patent and Trademark Office
General Counsel of a biotechnology company.
Counsel to an information technology company threatened by a large multinational corporation with intellectual property infringement. The case ended with a substantial settlement for the information technology company.
Counsel to a variety of clients managing all aspects of intellectual property protection, including successful international patent and trademark prosecution.
Counsel for a variety of early-stage companies assisting with corporate formation, financing, and contractual matters.
Successfully defended against trademark oppositions.
Patent invalidity and freedom to operate opinions.
Amicus (friend of the court) counsel for appellant who lost a trial for medical expenses for a lung transplant. The Appellate opinion held that immigration status is irrelevant to a personal injury action not claiming damages for lost earnings or earnings capacity, and that immigration status is not relevant to credibility.
Abbott, Ryan.I Think, Therefore I Invent: Creative Computers and the Future of Patent Law, Boston College Law Review, Vol. 57, No. 4 (2016).
Abbott, Ryan and Ian Ayres. Evidence and Extrapolation: Mechanisms for Regulating Off-Label Uses of Drugs and Devices, 64 Duke L.J. 377 (2014).
Abbot, Ryan. World Intellectual Property Organization, Documenting Traditional Medical Knowledge (2014).
Abbott, Ryan. Big Data and Pharmacovigilance: Using Healthcare Information Exchanges to Revolutionize Drug Safety, 99 Iowa L. Rev. 225 (2013).
Abbott, Ryan and Michael Cohen. Medico-Legal Issues in Cardiology. Cardiol Rev. 2013 Sep-Oct; 21(5):222-8.